drugset / Trial / NCT00736047
Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to determine the efficacy of high nicotine-specific antibody titers in smoking cessation.
Timeline
- Start
- 2008-08
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NIC002 | Vaccine | 100 ug | Subcutaneous |
Indications
No indication recorded.